Abstract
NISHIHIRA, T., HIRAYAMA, K., AKAISHI, T., SHINEHA, R., OKAYAMA, A. and MORI, S. Which Postoperative Combined Therapy Results in the Best Prognosis: Radiochemocytokine Therapy or Aggressive Chemotherapy? Tohoku J. Exp. Med., 1992, 168 (2), 431-435 - The recurrence of esophageal cancer involving regional nodes, even in patients who have undergone curative surgery, often takes place within three years after surgery. Thus, a new multidisciplinary treatment including cytokines or aggressive chemotherapy with active nutritional support to improve the prognosis in cancer of the thoracic esophagus has been adopted. - aggressive chemotherapy; radiochemocytokine therapy; esophageal cancer; postoperative adjuvant therapy; malignant factors
